Current Report Filing (8-k)

Datum : 22/04/2020 @ 22h36
Quelle : Edgar (US Regulatory)
Name : M D C Holdings Inc (MDC)
Kurs : 34.61  0.3 (0.87%) @ 23h15
M D C share price Chart
After Hours
Last Trade
Last $ 34,61 ◊ 0,00 (0,00%)

Current Report Filing (8-k)

false 0000773141 0000773141 2020-04-20 2020-04-20 0000773141 mdc:CommonStock01ParValueCustomMember 2020-04-20 2020-04-20 0000773141 mdc:SeniorNotesDueJanuary20436CustomMember 2020-04-20 2020-04-20

 



 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 


 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of Earliest Event Reported): April 20, 2020

 

MDC Holdings, Inc.


(Exact name of registrant as specified in its charter)

 

Delaware

1-8951

84-0622967

(State or other

(Commission file number)

(I.R.S. employer

jurisdiction of

 

identification no.)

incorporation)

   

 

4350 South Monaco Street, Suite 500, Denver, Colorado 80237


(Address of principal executive offices) (Zip code)

 

Registrant’s telephone number, including area code: (303) 773-1100


 

Not Applicable


(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading Symbol(s)

 

Name of each exchange on which registered

Common Stock, $.01 par value

 

 552676108

 

New York Stock Exchange

6% Senior Notes due January 2043

 

552676AQ1

 

New York Stock Exchange

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 



 

 

 

ITEM 1.01

ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT

 

M.D.C. Holdings, Inc. 2020 Equity Plan for Non-Employee Directors

 

On April 20, 2020, M.D.C. Holdings, Inc. (the "Company") held its 2020 Annual Meeting of Shareholders (the “2020 Annual Meeting”) at which the Company’s shareholders approved an amendment and restatement of the M.D.C. Holdings, Inc. 2011 Stock Option Plan for Non-Employee Directors renamed as the M.D.C. Holdings, Inc. 2020 Equity Plan for Non-Employee Directors (the “2020 Director Equity Plan”). The 2020 Director Equity Plan had been previously recommended for approval by the Company’s Compensation Committee of the Board of Directors and previously approved by the Company’s Board of Directors, in each case, subject to shareholder approval. The 2020 Director Equity Plan became effective as of the date of such shareholder approval – April 20, 2020.

 

In addition to the plan being renamed, the 2020 Director Equity Plan, among other things, increased the number of shares covered by the annual grant of each stock option (without increasing the total number of shares authorized under the plan) to reflect, on a going forward basis, the three stock dividends since the first effective date of the plan.

 

The material features of the 2020 Director Equity Plan are described in the section entitled “Proposal Three - Approval of Amendment and Restatement of the M.D.C. Holdings, Inc. 2020 Equity Plan for Non-Employee Directors” appearing on pages 61-68 of the Company’s definitive Proxy Statement on Schedule 14A filed on February 25, 2020 in connection with the 2020 Annual Meeting, which description is incorporated herein by reference. A copy of the 2020 Directory Equity Plan, as restated, is filed as Exhibit 10.1 hereto and incorporated herein by reference.

 

 

ITEM 5.07

SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

 

On April 20, 2020, the Company held its 2020 Annual Meeting. There were 63,052,543 shares of common stock entitled to vote at the meeting. The final voting results for each of the proposals submitted to a vote of shareholders at the 2020 Annual Meeting were as follows:

 

 

(1)

Election of three Class II Directors of the Company to serve for three-year terms expiring in 2023:

 

 

For

 

Withheld

 

Broker Non-Votes

David D. Mandarich

51,783,317

 

2,983,769

 

3,071,182

Paris G. Reece III

42,048,614

 

12,718,472

 

3,071,182

David Siegel

42,360,189

 

12,406,897

 

3,071,182

 

 

(2)

Approval, in a non-binding advisory vote, of the compensation of the Company’s named executive officers:

 

For

 

Against

 

Abstain

 

Broker Non-Votes

41,028,619

 

11,780,573

 

1,957,894

 

3,071,182

 

 

(3)

Approval of the amended and restated 2020 Director Equity Plan:

 

For

 

Against

 

Abstain

 

Broker Non-Votes

52,039,560

 

2,679,649

 

47,877

 

3,071,182

 

2

 

 

(4)

Ratification of the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the 2020 fiscal year:

 

For

 

Against

 

Abstain

   

56,979,036

 

823,703

 

35,529

   

 

 

ITEM 9.01.

FINANCIAL STATEMENTS AND EXHIBITS

 

(d) Exhibits

 

Exhibit Number

Description

   

10.1

M.D.C. Holdings, Inc. 2020 Equity Plan for Non-Employee Directors (as amended and restated)

   

104

Cover Page Interactive Data file (formatted in Inline XBRL)

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 


 

 

M.D.C. HOLDINGS, INC.

Dated: April 22, 2020

By:

/s/ Joseph H. Fretz 

Joseph H. Fretz

Secretary and Corporate Counsel

 

3

M D C (NYSE:MDC)
Historical Stock Chart


Von Jul 2019 bis Jul 2020

Click Here for more M D C Charts.

M D C (NYSE:MDC)
Intraday Stock Chart


Sonntag 5 Juli 2020

Click Here for more M D C Charts.
Kürzlich von Ihnen besucht
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

Der Markt LS (Lang&Schwarz) wird als Realtime Indikation kostenlos angezeigt und bietet Ihnen außerbörsliche Realtime Aktienkurse in der Zeit von Mo-Fr 08:00 bis 23:00, Samstags 10:00 bis 13:00 und Sonntags an.
NYSE und AMEX Kurse sind um mindestens 20 Minuten zeitverzögert.
Alle weiteren Kurse sind um mindestens 15 Minuten zeitverzögert, sofern nicht anders angegeben.
P: V:de D:20200705 01:48:38